Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prothena Corp
(NQ:
PRTA
)
20.56
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
20.56
Bid (Size)
20.00 (1)
Ask (Size)
20.88 (1)
Prev. Close
20.56
Today's Range
20.56 - 20.56
52wk Range
20.32 - 79.65
Shares Outstanding
45,047,449
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
April 15, 2024
From
Prothena Corporation plc
Via
Business Wire
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
March 28, 2024
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.
Via
Investor's Business Daily
Exposures
Product Safety
Performance
YTD
-46.65%
-46.65%
1 Month
-19.06%
-19.06%
3 Month
-37.56%
-37.56%
6 Month
-48.19%
-48.19%
1 Year
-62.09%
-62.09%
More News
Read More
Demystifying Prothena Corp: Insights From 8 Analyst Reviews
March 13, 2024
Via
Benzinga
Prothena to Participate in Upcoming Healthcare Conferences
March 05, 2024
From
Prothena Corporation plc
Via
Business Wire
Decoding 6 Analyst Evaluations For Prothena Corp
February 16, 2024
Via
Benzinga
Prothena Corp: Q4 Earnings Insights
February 15, 2024
Via
Benzinga
Earnings Scheduled For February 15, 2024
February 15, 2024
Via
Benzinga
Prothena Appoints David Ford to Newly Created Chief People Officer Position
March 04, 2024
From
Prothena Corporation plc
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
Via
Benzinga
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
February 21, 2024
From
Prothena Corporation plc
Via
Business Wire
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
February 15, 2024
From
Prothena Corporation plc
Via
Business Wire
Earnings Outlook For Prothena Corp
February 14, 2024
Via
Benzinga
Navigating 5 Analyst Ratings For Prothena Corp
January 25, 2024
Via
Benzinga
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
February 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 30, 2024
Via
Benzinga
$100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today
January 22, 2024
Via
Benzinga
Demystifying Prothena Corp: Insights From 5 Analyst Reviews
January 09, 2024
Via
Benzinga
4 Analysts Have This to Say About Prothena Corp
December 18, 2023
Via
Benzinga
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
January 09, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 08, 2024
Via
Benzinga
Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday
January 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs
January 08, 2024
From
Prothena Corporation plc
Via
Business Wire
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
November 21, 2023
Via
Benzinga
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
November 17, 2023
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.